Author:
Poorcheraghi Hossein,Negarandeh Reza,Pashaeypoor Shahzad,Jorian Javad
Abstract
Abstract
Background
Adherence to complex drug regimens and polypharmacy are among the challenges of old age, which may negatively affect their motivation to continue drug therapy or lead to incorrect drug consumption. The present study was conducted to evaluate the effect of using a mobile drug management application on medication adherence and hospital readmission among polypharmacy older adults.
Methods
In this randomized controlled trial study conducted in 2022, with Trial Registration Number (IRCT20191231045966N1) (18/07/2021), 192 Iranian older adults with polypharmacy were selected according to the inclusion criteria and allocated to case and control groups using the block randomization method. The data collection tools included a demographic questionnaire, case report form, and Morisky Medication Adherence Scale. The intervention was done using a mobile drug management application. Drug adherence was measured at baseline and both with hospital readmission were measured after 8 weeks. The collected data were entered into the SPSS software version 22 and analyzed using descriptive (frequency, percentage, mean, standard deviation) and inferential (Chi-square, Fisher’s exact test, independent t-test) statistics.
Results
The case and control groups were homogeneous in terms of demographic variables and drug adherence level before the intervention. A significant difference was found in the drug adherence level after using the app (p < 0.001). Moreover, a significant difference was found in adverse events, including re-hospitalization due to disease aggravation, re-hospitalization due to error in medication consumption, falling, hypo or hypertension, and hypo or hyperglycemia, and medication use accuracy between the groups after the intervention (p < 0.05).
Conclusion
The results showed that using a mobile drug management application that meets the specifications of older adults can improve drug adherence, reduce the adverse events and pave the way for a better disease period management.
Funder
Tehran University of Medical Sciences and Health Services
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Aghamohamadi S, Hajinabi K, Jahangiri K, Asl IM, Dehnavieh R. Population and mortality profile in the Islamic Republic of Iran, 2006–2035. East Mediterr Health J. 2018;24(5):469–76.
2. Curtin D, O’mahony D, Gallagher P. Drug consumption and futile medication prescribing in the last year of life: an observational study. Age Ageing. 2018;47(5):749–53.
3. Poorcheraghi H, Valieiny N, Pashaeypoor S, Mirzadeh FS. Polypharmacy Management Strategies in older adults; a scoping review. Iran J Nurs Res. 2022;17(5):71–87.
4. Dhalwani NN, Fahami R, Sathanapally H, Seidu S, Davies MJ, Khunti K. Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ open. 2017;7(10):e016358.
5. Hosseini SR, Zabihi A, Amiri SRJ, Bijani A. Polypharmacy among the Elderly. J mid-life Health. 2018;9(2):97.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献